Peter A Margolis
Overview
Explore the profile of Peter A Margolis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1045
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adler J, Galanko J, Ammoury R, Benkov K, Bousvaros A, Boyle B, et al.
Am J Gastroenterol
. 2024 Oct;
PMID: 39423015
Objectives: HLA DQA1*05 has been associated with the development of anti-drug antibodies (ADA) to tumor necrosis factor antagonists (anti-TNF) and treatment failure among adults with Crohn's disease (CD). However, findings...
2.
Moses J, Adler J, Saeed S, Firestine A, Galanko J, Ammoury R, et al.
Inflamm Bowel Dis
. 2024 Oct;
PMID: 39418336
Background: Higher drug levels and combination therapy with low-dose oral methotrexate (LD-MTX) may reduce anti-tumor necrosis factor (TNF) treatment failure in pediatric Crohn's disease. We sought to (1) evaluate whether...
3.
Beck A, Mattingly T, Brokamp C, Sahay R, Manning E, Taylor S, et al.
J Public Health Manag Pract
. 2024 Sep;
31(1):61-64.
PMID: 39321404
As the COVID-19 pandemic progressed, reliable, accessible, and equitable community-based testing strategies were sought that did not flood already overburdened hospitals and emergency departments. In Hamilton County, Ohio, home to ...
4.
Elia J, Pajer K, Prasad R, Pumariega A, Maltenfort M, Utidjian L, et al.
Child Adolesc Psychiatry Ment Health
. 2023 Sep;
17(1):107.
PMID: 37710303
Background: Electronic health records (EHRs) data provide an opportunity to collect patient information rapidly, efficiently and at scale. National collaborative research networks, such as PEDSnet, aggregate EHRs data across institutions,...
5.
Kappelman M, Wohl D, Herfarth H, Firestine A, Adler J, Ammoury R, et al.
Gastroenterology
. 2023 Apr;
165(1):149-161.e7.
PMID: 37004887
Background & Aims: Tumor necrosis factor inhibitors, including infliximab and adalimumab, are a mainstay of pediatric Crohn's disease therapy; however, nonresponse and loss of response are common. As combination therapy...
6.
Seid M, Hartley D, Margolis P
Learn Health Syst
. 2021 Jul;
5(3):e10278.
PMID: 34277944
Introduction: Improving the U.S. healthcare system and health outcomes is one of the most pressing public health challenges of our time. Previously described Collaborative Learning Health Systems (CLHSs) are a...
7.
Keck C, Hartley D, Havens M, Margolis P, Seid M
Learn Health Syst
. 2021 Jul;
5(3):e10268.
PMID: 34277941
Background: Collaborative Learning Health Systems (CLHS) improve outcomes in part by facilitating collaboration among all stakeholders. One way to facilitate collaboration is by creating conditions for the production and sharing...
8.
Lannon C, Schuler C, Seid M, Provost L, Fuller S, Purcell D, et al.
Learn Health Syst
. 2021 Apr;
5(2):e10232.
PMID: 33889737
Background: The vision of learning healthcare systems (LHSs) is attractive as a more effective model for health care services, but achieving the vision is complex. There is limited literature describing...
9.
Hartley D, Keck C, Havens M, Margolis P, Seid M
Learn Health Syst
. 2021 Apr;
5(2):e10225.
PMID: 33889734
Background: Collaborative learning health systems have demonstrated improved outcomes for a range of different chronic conditions. Patient and healthcare provider engagement in these systems is thought to be associated with...
10.
Beck A, Hartley D, Kahn R, Taylor S, Bishop E, Rich K, et al.
Mayo Clin Proc
. 2021 Mar;
96(4):849-855.
PMID: 33714596
No abstract available.